Abstract
The U.S. Alzheimer' s disease medication markets research service provides
revenue and patient forecasts, competitive analysis, market trends, product
analysis and strategies for growth. The market is segmented by product type
into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism
drugs. Each of the segments discusses in detail marketed products, revenue
forecasts, product pipeline and competitive structure.
View Cart
